Mullis, Primus E.

Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase

Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology

Pharmacogenetics and Drug MetabolismAdrenal Hormones and Disorders

Cited by 132

Effects of Dietary Fat on Muscle Substrates, Metabolism, and Performance in Athletes

VOGT, M., PUNTSCHART, A., HOWALD, H., MUELLER, B., MANNHART, C., GFELLER-TUESCHER, L., MULLIS, P., & HOPPELER, H. (2003) · Medicine & Science in Sports & Exercise

Muscle metabolism and nutritionCardiovascular and exercise physiology

Cited by 120

Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain

Hirsch, A., Hahn, D., Kempná, P., Hofer, G., Nuoffer, J.-M., Mullis, P. E., & Flück, C. E. (2012) · Endocrinology

Ovarian function and disordersMetabolism, Diabetes, and Cancer

Cited by 109

Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia

Flück, C. E., Pandey, A. V., Dick, B., Camats, N., Fernández-Cancio, M., Clemente, M., Gussinyé, M., Carrascosa, A., Mullis, P. E., & Audi, L. (2011) · PLoS ONE

Adrenal Hormones and DisordersSexual Differentiation and Disorders

Cited by 94

Role of DNA methylation in the tissue-specific expression of the CYP17A1 gene for steroidogenesis in rodents

Missaghian, E., Kempná, P., Dick, B., Hirsch, A., Alikhani-Koupaei, R., Jégou, B., Mullis, P. E., Frey, B. M., & Flück, C. E. (2009) · Journal of Endocrinology

Epigenetics and DNA MethylationAdrenal Hormones and Disorders

Cited by 91

A novel mutation L260P of the steroidogenic acute regulatory protein gene in three unrelated patients of Swiss ancestry with congenital lipoid adrenal hyperplasia

Flück, C. E., Maret, A., Mallet, D., Portrat-Doyen, S., Achermann, J. C., Leheup, B., Theintz, G. E., Mullis, P. E., & Morel, Y. (2005) · The Journal of Clinical Endocrinology & Metabolism

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 59

Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism

Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 59

Human 3β-hydroxysteroid dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature

Burckhardt, M.-A., Udhane, S. S., Marti, N., Schnyder, I., Tapia, C., Nielsen, J. E., Mullis, P. E., Rajpert-De Meyts, E., & Flück, C. E. (2015) · European Journal of Endocrinology

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 49

Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase

Pandey, A. V., Flück, C. E., & Mullis, P. E. (2010) · Biochemical and Biophysical Research Communications

Heme Oxygenase-1 and Carbon MonoxideNeonatal Health and Biochemistry

Cited by 36

Acute encephalopathy with unilateral cortical-subcortical lesions in two unrelated kindreds treated with glucocorticoids prenatally for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: established facts and novel insight

Grunt, S., Steinlin, M., Weisstanner, C., Schöning, M., Mullis, P. E., & Flück, C. E. (2013) · Hormone Research in Paediatrics

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 13